...
机译:索拉非尼的多中心期II临床试验结合晚期肝细胞癌常规化疗栓塞(巴塞罗那临床肝癌阶段C):刺伤研究
Department of Diagnostic and Interventional Radiology Aichi Cancer Center Hospital;
Department of Radiology Nara Medical University;
Department of Radiology Toyonaka Municipal Hospital;
Department of Radiology Mie University School of Medicine;
Department of Radiology Narumi Hospital;
Department of Radiology Teine Keijinkai Hospital;
Department of Gastroenterology Juntendo University Nerima Hospital;
Department of Radiology Hokkaido University Graduate School of Medicine;
Department of Radiology Hyogo College of Medicine;
Department of Diagnostic and Interventional Radiology Aichi Cancer Center Hospital;
Department of Radiology Hyogo College of Medicine;
机译:索拉非尼的多中心期II临床试验结合晚期肝细胞癌常规化疗栓塞(巴塞罗那临床肝癌阶段C):刺伤研究
机译:肝动脉输液化疗用细粉顺铂和碘油悬浮液中中期和先进阶段(巴塞罗那临床肝癌阶段-B或Stage-C)肝癌:多中心期 - II临床研究
机译:巴塞罗那肿瘤门诊肝癌A期或B期肝细胞癌患者,无论肿瘤大小如何,均采用经动脉化学栓塞联合射频消融治疗可改善临床疗效:单中心回顾性病例对照研究的结果
机译:Sorafenib之外的肝细胞癌中的分子疗法:III期试验失败的课程和新型靶标
机译:临床前癌症模型的临床预测价值:体外细胞系,人异种移植和小鼠同种异体移植临床前癌症模型对细胞毒性癌症药物II期临床试验的预测价值研究
机译:巴塞罗那肿瘤门诊肝癌A期或B期肝细胞癌患者无论肿瘤大小如何均采用经动脉化学栓塞联合射频消融术改善临床疗效:单中心回顾性病例对照研究的结果
机译:改善使用relarterial Chemoembolization的临床结果与巴塞罗那诊所肝癌肝癌阶段A或B肝细胞癌患者的射频消融结合,无论肿瘤大小如何:单中心回顾性案例控制研究的结果